[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100467662":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":29,"responsibleParty":42,"collaborators":10,"id":46,"slug":10,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":57,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":10,"overallStatus":65,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Peking University Third Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"spinal tumors, CT, MRI, PET-CT stereotactic radiosurgery",null,"Patients who had spinal tumors and completed the CT, MRI or PET-CT examination before and after stereotactic radiosurgery.",[13],"Other: No interventions",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"No interventions","As this is a prognosis evaluation study, there are no interventions.",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Hongqing zhuang","CONTACT","82264910","hongqingzhuang@163.com",{"name":26,"role":22,"phone":27,"phoneExt":10,"email":28},"Mingqing Wang","82264917","wangronggang.love@163.com",[30],{"facility":31,"status":10,"city":32,"state":33,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":10},"Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist.","Beijing","Beijing Municipality","100191","China",{"type":37,"coordinates":38},"Point",[39,40],116.39723,39.9075,{"lat":40,"lon":39},{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Zhuang Hongqing","Associate department chairman of radiotherapy","100467662",false,"NCT05369689","Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics","Inclusion Criteria:\n\nA diagnosis of spinal tumors for which SBRT is appropriate Karnofsky Performance Status \\>60 Life expectancy of at least 3 months No contraindication to undergoing MR imaging Age \\>18 Complete the CT MRI or PET-CT examination before and after treatment Accept stereotactic radiosurgery\n\nExclusion Criteria:\n\nSubjects unable to undergo MRI (includes non-MRI compatible material or devices and severe claustrophobia) Subjects with prior procedural intervention to the involved vertebral body that would result in artifact (kyphoplasty, screw and\u002For rod placement); minimally invasive surgery without instrumentation of the involved vertebral body and instrumentation immediately above or below the index lesion is allowed.\n\nSubjects with spinal cord compression; minimally invasive \"separation\" surgery to first resect the epidural component is allowed Pregnant or breast-feeding women Allergy to standard IV contrast agents used in MRI","ALL","18 Years","80 Years",{"count":55,"type":56},300,"ESTIMATED","5 Years","OBSERVATIONAL","This study aims to assess multimodal Radiomics-based prediction model for prognostic prediction in spinal tumors.",[61,62,63,64],"Stereotactic Radiosurgery","Spinal Tumor","Radiomics","Prognosis","NOT_YET_RECRUITING","2022-05-07",{"date":68,"type":69},"2022-05-11","ACTUAL",{"date":71,"type":56},"2022-06-01",{"date":73,"type":56},"2027-06-01",{"name":44,"class":6},1]